You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

383 Results
Regimen
Cancer Type:
Genitourinary, 
Renal cell / Kidney
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
ODB - General Benefit
    everolimus
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
lenvatinib (Unfunded),
everolimus
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Updated
Dec 2025
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Hodgkin
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Funding:
New Drug Funding Program
    Nivolumab - In Combination with Chemotherapy for Previously Untreated Advanced Stage Hodgkin Lymphoma
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
DOXOrubicin,
vinBLAStine,
dacarbazine,
nivolumab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Updated
Dec 2025
Drug
Other Name(s): Xgeva®; Wyost™; Osenvelt™
Quick Link(s):
Drug Monograph, Patient Info Sheet
Updated
Dec 2025
Drug
Other Name(s): Truqap™
Quick Link(s):
Drug Monograph, Patient Info Sheet
Updated
Dec 2025
Drug
Other Name(s): Vitrakvi®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Updated
Dec 2025
Drug
Other Name(s): Elrexfio™
Quick Link(s):
Drug Monograph, Patient Info Sheet
Updated
Dec 2025
Drug
Other Name(s): Rybrevant®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Updated
Dec 2025
Drug
Other Name(s): Vyloy®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Updated
Dec 2025
Drug
Other Name(s): Votrient®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Updated
Dec 2025
Guidelines and Advice
Status: Current
Version: 1
Updated
Nov 2025
Drug
Other Name(s): Opdivo®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Updated
Dec 2025

Pages